Theseus Pharmaceuticals is passionately committed to outsmarting cancer resistance. Cancer is constantly mutating, allowing it to evade initially effective oncology treatments. Theseus believes we can predict how cancer will change, enabling new therapies to stay ahead of future mutations and overcome the demonstrated burden of treatment resistance. Led by a team of pioneers in the discovery and development of tyrosine kinase inhibitors (TKIs), we are developing best-in-class, pan-variant kinase inhibitors, to shape the future of targeted oncology.
Employees: 11-50
Total raised: $100M
Founded date: 2017
Investors 4
| Date | Name | Website |
| - | Foresite C... | foresiteca... |
| 04.05.2021 | Omega Fund... | omegafunds... |
| - | OrbiMed | orbimed.co... |
| 28.04.2021 | Longitude ... | longitudec... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.04.2021 | Series B | $100M | Foresite C... |
Mentions in press and media 12
| Date | Title | Description | Source |
| 14.11.2023 | Legend Biotech’s deal with Novartis is a reminder that biote... | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 02.02.2022 | Theseus Pharmaceuticals Receives U.S. FDA Orphan Drug Design... | CAMBRIDGE, Mass., Feb. 2, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (Theseus) (NASDAQ: THRX... | marketscre... |
| 10.01.2022 | Theseus Pharmaceuticals Announces First Patient Treated with... | CAMBRIDGE, Mass., Jan. 10, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (Theseus) (NASDAQ: THR... | marketscre... |
| 15.11.2021 | Theseus Pharmaceuticals Announces Business and Program Highl... | CAMBRIDGE, Mass., Nov. 15, 2021 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX), a biop... | marketscre... |
| 01.11.2021 | Theseus Pharmaceuticals Announces FDA Clearance of Investiga... | CAMBRIDGE, Mass., Nov. 1, 2021 /PRNewswire/ --Theseus Pharmaceuticals, Inc. ("Theseus"), a... | marketscre... |
| 04.05.2021 | Theseus Pharmaceuticals Appoints Tim Clackson, Ph.D., as Chi... | CAMBRIDGE, Mass., May 4, 2021 /PRNewswire/ -- Theseus Pharmaceuticals, a biotechnology company sha... | prnewswire... |
| 13.04.2021 | Theseus Pharmaceuticals Debuts with $100M Series B Raise to ... | - | orbimed.co... |
| 13.04.2021 | Theseus Pharmaceuticals Debuts with $100M Series B Raise to ... | BOSTON, April 13, 2021 /PRNewswire/ -- Theseus Pharmaceuticals, a biotechnology company shaping th... | prnewswire... |
| 13.04.2021 | Theseus Pharmaceuticals, Inc. announced that it has received... | On April 13, 2021, Theseus Pharmaceuticals, Inc. closed the transaction. The company has raised $100... | marketscre... |
| 13.04.2021 | Theseus Pharmaceuticals Emerges With $100M | BOSTON, MA, Theseus Pharmaceuticals emerged from stealth today announcing the close of a $100 mill... | vcnewsdail... |
Show more